CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Cipla USA, Inc. recalls Diclofenac Sodium Topical Gel

Read the official FDA notice

Published
28 Jan 2026
Units affected
92,376 tubes
Agency
FDA
Country
United States

The hazard

Failed PH Specifications

Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX 78215. NDC: 76282-103-39

Brand / company
Cipla USA, Inc.
Codes / lots
Batch XHBG; Exp. 08/31/2027
Distribution
Nationwide in the USA
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 28 Jan 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.